Literature DB >> 24871456

High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response.

Berta Pernas1, Marta Grandal, Alvaro Mena, Angeles Castro-Iglesias, Angelina Cañizares, David L Wyles, Soledad López-Calvo, Sonia Pértega, Iria Rodríguez-Osorio, Jose Domingo Pedreira, Eva Poveda.   

Abstract

HIV-1 non-B subtype variants were found in 37.8% of 296 newly diagnosed persons in northwest Spain over the past 5 years. Subtype F was the most prevalent non-B subtype (29.6%) and displayed preferential transmission among MSM. Virologic response rates to antiretroviral therapy were lower among F subtypes compared to B subtypes at weeks 24 (31% vs. 78.3%), 48 (51.7% vs. 85.2%), and 96 (61.1% vs. 94.3%) of therapy. Subtype F was independently associated with virological response at 24 weeks.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24871456     DOI: 10.1097/QAD.0000000000000326

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

1.  Genome-scale analysis of evolutionary rate and selection in a fast-expanding Spanish cluster of HIV-1 subtype F1.

Authors:  Juan Á Patiño-Galindo; Francisco Domínguez; María T Cuevas; Elena Delgado; Mónica Sánchez; Lucía Pérez-Álvarez; Michael M Thomson; Rafael Sanjuán; Fernando González-Candelas; José M Cuevas
Journal:  Infect Genet Evol       Date:  2018-09-13       Impact factor: 3.342

2.  Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012).

Authors:  Juan Ambrosioni; Omar Sued; David Nicolas; Marta Parera; María López-Diéguez; Anabel Romero; Fernando Agüero; María Ángeles Marcos; Christian Manzardo; Laura Zamora; Manuel Gómez-Carrillo; José María Gatell; Tomás Pumarola; José María Miró
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

3.  Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing.

Authors:  Alvaro Mena; Luz Moldes; Héctor Meijide; Angelina Cañizares; Angeles Castro-Iglesias; Manuel Delgado; Sonia Pértega; José Pedreira; Germán Bou; Eva Poveda
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

4.  HIV-1 Variants and Drug Resistance in Pregnant Women from Bata (Equatorial Guinea): 2012-2013.

Authors:  Patricia Alvarez; Carolina Fernández McPhee; Luis Prieto; Leticia Martín; Jacinta Obiang; Pedro Avedillo; Antonio Vargas; Pablo Rojo; Agustín Benito; José Tomás Ramos; África Holguín
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

5.  Phylodynamic and Phylogeographic Profiles of Subtype B HIV-1 Epidemics in South Spain.

Authors:  Santiago Pérez-Parra; Natalia Chueca; Marta Álvarez; Juan Pasquau; Mohamed Omar; Antonio Collado; David Vinuesa; Ana B Lozano; Gonzalo Yebra; Federico García
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

6.  Contrasting antibody responses to intrasubtype superinfection with CRF02_AG.

Authors:  Colleen R Courtney; Luzia Mayr; Aubin J Nanfack; Andrew N Banin; Michael Tuen; Ruimin Pan; Xunqing Jiang; Xiang-Peng Kong; Allison R Kirkpatrick; Daniel Bruno; Craig A Martens; Lydia Sykora; Stephen F Porcella; Andrew D Redd; Thomas C Quinn; Phillipe N Nyambi; Ralf Dürr
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

7.  Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay.

Authors:  Nicholas Silver; Mary Paynter; Georgina McAllister; Maureen Atchley; Christine Sayir; John Short; Dane Winner; David J Alouani; Freddie H Sharkey; Kicki Bergefall; Kate Templeton; David Carrington; Miguel E Quiñones-Mateu
Journal:  AIDS Res Ther       Date:  2018-11-08       Impact factor: 2.250

8.  HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.

Authors:  Francis Kiweewa; Allahna Esber; Ezra Musingye; Domonique Reed; Trevor A Crowell; Fatim Cham; Michael Semwogerere; Rosemary Namagembe; Alice Nambuya; Cate Kafeero; Allan Tindikahwa; Leigh Anne Eller; Monica Millard; Huub C Gelderblom; Babajide Keshinro; Yakubu Adamu; Jonah Maswai; John Owuoth; Valentine Chepkorir Sing'oei; Lucas Maganga; Emmanuel Bahemana; Samoel Khamadi; Merlin L Robb; Julie A Ake; Christina S Polyak; Hannah Kibuuka
Journal:  PLoS One       Date:  2019-02-05       Impact factor: 3.240

9.  Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe.

Authors:  Elena Delgado; María Teresa Cuevas; Francisco Domínguez; Yolanda Vega; Marina Cabello; Aurora Fernández-García; Marcos Pérez-Losada; María Ángeles Castro; Vanessa Montero; Mónica Sánchez; Ana Mariño; Hortensia Álvarez; Patricia Ordóñez; Antonio Ocampo; Celia Miralles; Sonia Pérez-Castro; María José López-Álvarez; Raúl Rodríguez; Matilde Trigo; Julio Diz-Arén; Carmen Hinojosa; Pablo Bachiller; Silvia Hernáez-Crespo; Ramón Cisterna; Eugenio Garduño; Lucía Pérez-Álvarez; Michael M Thomson
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

10.  SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression.

Authors:  Hortensia Álvarez; Ezequiel Ruiz-Mateos; Pedro Miguel Juiz-González; Joana Vitallé; Irene Viéitez; María Del Carmen Vázquez-Friol; Isabel Torres-Beceiro; Alberto Pérez-Gómez; Pilar Gallego-García; Nuria Estévez-Gómez; Loretta De Chiara; Eva Poveda; David Posada; Josep M Llibre
Journal:  Microorganisms       Date:  2022-01-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.